AstraZeneca hails ‘breakthrough’ treatment for high-risk Covid patients

18 November 2021

“Compelling” new research shows that an antibody cocktail developed by AstraZeneca can significantly reduce the risk of hospitalisation and death from Covid-19 for the most vulnerable people, says Professor Hugh Montgomery (UCL Medicine).